A multi-centre study to compare meropenem and cefotaxime and metronidazole in the treatment of hospitalized patients with serious infections

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 5, 1997, Pages 631-638

  Mehtar, S ^a   Dewar, E P ^b   Leaper, D J ^c   Taylor, E W ^d  

^a NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL HOSPITAL HASLAR   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; MEROPENEM; METRONIDAZOLE;

ABDOMINAL INFECTION; ADOLESCENT; ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG RESPONSE; FEMALE; HOSPITAL INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEFOTAXIME; FEMALE; HOSPITALIZATION; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; PROSPECTIVE STUDIES; THIENAMYCINS; TREATMENT OUTCOME;

EID: 0030913711     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.5.631     Document Type: Article

References (23)

1. Hackford, A. W. (1990). Intra-abdominal sepsis: a medical-surgical dilemma. Clinical Therapeutics 12, Suppl. B, 43-53.
2. Jones, R. N., Barry, A. L. & Thornberry, C. J. (1989). ln-vitro studies of meropenem. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 9-29.
3. Yourassowsky, E., Van der Linden, M. P., Lismont, M. J., Crokaert, F. & Glupczynski, Y. (1989). Bactericidal activity of meropenem against Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 169-74.
4. Yourassowsky, E., Van der Linden, M. P. & Crokaert, F. (1990). Antibacterial effect of meropenem and imipenem on Proteus mirabilis. Journal of Antimicrobial Chemotherapy 26, 185-92.
5. Sumita, Y., Fukasawa, M. & Okuda, T. (1990). Affinities of SM-7338 for penicillin-binding proteins and its release from these proteins in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 34, 484-6.
6. Voutsinas, D., Mavroudis, T., Avlamis, A. & Giamarellou, H. (1989). In-vitro activity of meropenem, a new carbapenem, against multiresistant Pseudomonas aeruginosa compared with that of other antipseudomonal antimicrobials. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 143-7.
7. Bedikian, A., Okamoto, M. P., Nakahiro, R. K., Farino, J., Heseltine, P. N., Appleman, M. D. et al. (1994). Pharmacokinetics of meropenem in patients with intra-abdominal infections. Antimicrobial Agents and Chemotherapy 38, 151-4.
8. Levering, A. M., Vickery, C. J., Watkins, D. S., Leaper, D., McMullin, C. M., White, L. O. et al. (1995). The pharmacokinetics of meropenem in surgical patients with moderate or severe infections. Journal of Antimicrobial Chemotherapy 36, 165-72.
9. Brismar, B., Malmborg, A. S., Tunevall, G., Lindgren, V., Bergman, L., Mentzing, L. O. et al. (1995). Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections. Journal of Antimicrobial Chemotherapy 35, 139-48.
10. Huizinga, W. K. J., Warren, B. L., Baker, L. W., Valleur, P., Pezet, D. M., Hoogkamp-Korstanje, J. A. A. et al. (1995), Antibiotic monotherapy with meropenem in the surgical management of intra-abdominal infections. Journal of Antimicrobial Chemotherapy 36, Suppl. A, 179-89.
11. Geroulanos, S. J. and the Meropenem Study Group. (1995). Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Journal of Antimicrobial Chemotherapy 36, Suppl. A, 191-205.
12. Solberg, C. O. & Sjursen, H. (1995). Safety and efficacy of meropenem in patients with septicaemia: a randomized comparison with ceftazidime, alone or combined with amikacin. Journal of Antimicrobial Chemotherapy 36, Suppl. A, 157-66.
13. Mouton, Y. J. & Beuscart, C. M. (1994). Respiratory tract infections and resistance in the intensive care unit. Current Opinion in Infectious Diseases 7, Suppl. A, S23-9.
14. Cox, C. E., Holloway, W. J. & Geckler, R. W. (1995). A multi-center comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. Clinical Infectious Diseases 21, 86-92.
15. Martens, M. & Hemsell, D. (1993). A comparison of meropenem and clindamycin-gentamicin in the treatment of obstetric and gynaecologic infections. In Program and Abstracts of the Thirty-Third Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1993. Abstract 639, p. 236. American Society for Microbiology, Washington, DC.
16. Nichols, R. L., Smith, J. W., Geckler, R. W. & Wilson, S. E. (1995). Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections. Southern Medical Journal 88, 397-404.
17. Norrby, S. R., Newell, P. A., Faulkner, K. L. & Lesky, W. (1995). Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem. Journal of Antimicrobial Chemotherapy 36, Suppl. A, 207-23.
18. Knaus, W. A., Draper, E. A., Wagner, D. P. & Zimmerman, J, E. (1985). APACHE II: a severity of disease classification system. Critical Care Medicine 13, 818-29.
19. Stokes, E. J., Ridgway, G. L. & Wren, M. W. D. (1993). Clinical Microbiology, 7th edn, pp. 241-4. Edward Arnold, London.
20. Working Party Report of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 1-50.
21. Condon, R. E., Walker, P. A., Sirinek, K. R. et al. (1995). Meropenem versus tobramycin plus clindamycin for treatment of intra-abdominal infections: results of a prospective, randomized, double blind clinical trial. Clinical Infectious Diseases 21, 544-50.
22. Norrby, S. R., Vandercam, B., Louie, T., Runde, V., Norberg, B., Anniko, M. et al. (1987). Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study. Scandinavian Journal of Infectious Diseases, Suppl. 52, 65-78.
23. Winston, D. J., Ho, W. G., Bruckner, D. A. & Champlin, R. E. (1991). Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone. Annals of Internal Medicine 115, 849-59.